Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients
NCT ID: NCT03899389
Last Updated: 2019-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2017-02-01
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that in patients with recent myocardial infarction, TMAO concentration in blood is higher than in patients undergoing scheduled coronarography.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of TMAO Serum Levels on Hyperemic IMR in STEMI Patients
NCT05406297
Exercise Test and Cardiac Injury
NCT01660828
Influence of Renal Function on the Circadian Variation of Cardiac Troponin
NCT02210897
Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
NCT04167904
Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease
NCT02626806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute Coronary Syndrome (ACS)
Patients with STEMI or NSTEMI infarction, who were admitted to the hospital with chest pain.
plasma samples collection
Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples
Stable Angina (SA)
Patients with stable angina who were scheduled for conventional coronary angiography.
plasma samples collection
Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples
Control Group (CON)
Healthy control group responding by age and gender to examined groups.
plasma samples collection
Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
plasma samples collection
Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gdansk University of Physical Education and Sport
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Olek
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert A Olek, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Physical Education and Sport in Gdansk
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Physical Education and Sport
Gdansk, Pomeranian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSRiK/10/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.